載入...
Bevacizumab in Combination With Radiotherapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma Multiforme
BACKGROUND. Patients with a newly diagnosed glioblastoma multiforme (GBM) have a high risk of recurrent disease with a dismal outcome despite intensive treatment of sequential surgery and chemoradiotherapy with temozolomide (TMZ), followed by TMZ as a single agent. Bevacizumab (BV) may increase resp...
Na minha lista:
| 發表在: | Oncologist |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
AlphaMed Press
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4319643/ https://ncbi.nlm.nih.gov/pubmed/25582142 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0418 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|